J.-P. Machiels

1.8k total citations · 1 hit paper
34 papers, 1.1k citations indexed

About

J.-P. Machiels is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, J.-P. Machiels has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 14 papers in Otorhinolaryngology. Recurrent topics in J.-P. Machiels's work include Head and Neck Cancer Studies (14 papers), Lung Cancer Treatments and Mutations (13 papers) and Cancer Immunotherapy and Biomarkers (4 papers). J.-P. Machiels is often cited by papers focused on Head and Neck Cancer Studies (14 papers), Lung Cancer Treatments and Mutations (13 papers) and Cancer Immunotherapy and Biomarkers (4 papers). J.-P. Machiels collaborates with scholars based in Belgium, France and Italy. J.-P. Machiels's co-authors include Lisa Licitra, Cai Grau, Vincent Grégoire, C. René Leemans, Wojciech Golusiński, Kevin J. Harrington, Carla M.L. van Herpen, Shree Bhide, Chris Nutting and C. Kelly and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J.-P. Machiels

33 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2020 477 citations J.-P. Machiels, C. René Leemans et al. Annals of Oncology profile →

Peers

Countries citing papers authored by J.-P. Machiels

Since Specialization

Citations

This map shows the geographic impact of J.-P. Machiels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Machiels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Machiels more than expected).

Fields of papers citing papers by J.-P. Machiels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. Machiels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Machiels. The network helps show where J.-P. Machiels may publish in the future.

Co-authorship network of co-authors of J.-P. Machiels

This figure shows the co-authorship network connecting the top 25 collaborators of J.-P. Machiels. A scholar is included among the top collaborators of J.-P. Machiels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-P. Machiels. J.-P. Machiels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LBA36 A randomised phase II study to evaluate the efficacy and safety of androgen deprivation therapy (ADT) vs chemotherapy (CT) in patients with recurrent and/or metastatic, androgen receptor (AR) expressing, salivary gland cancers 2024 ·Annals of Oncology ·Lisa Licitra, Laura D. Locati, Laurence Digue, (unknown), (unknown), (unknown), Sebastian Ochsenreither, (unknown), (unknown), J.-P. Machiels, Thorsten Fuereder, (unknown), Pasquale Quattrone, (unknown), Federica Perrone, Marika Rasschaert, Axelle Nzokirantevye, Ana Joaquim, (unknown), C. Lefèvre	1
2	Health-Related Quality of Life (HRQoL) Data From KEYNOTE-412: Chemoradiotherapy (CRT) with or Without Pembrolizumab (pembro) in Patients (pts) with Locally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC) 2024 ·International Journal of Radiation OncologyBiologyPhysics ·J.-P. Machiels, (unknown), Barbara Burtness, Makoto Tahara, Danny Rischin, (unknown), (unknown), (unknown), Y. Pointreau, Sercan Aksoy, Simon Laban, Richard Greil, Martin Burian, Marcin Hetnał, Lisa Licitra, Christopher M. Black, Josephine M. Norquist, (unknown), Behzad Bidadi, Lillian L. Siu	0
3	Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence 2023 ·Oral Oncology ·Kevin J. Harrington, Ezra E.W. Cohen, Denis Soulières, José Dinis, Lisa Licitra, Myung‐Ju Ahn, Ainara Soria, J.-P. Machiels, Nicolas Mach, Ranee Mehra, Barbara Burtness, Ramona F. Swaby, J. Lin, Joy Yang Ge, (unknown), Christophe Le Tourneau	7
4	ESMO–EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease 2022 ·Annals of Oncology ·Paolo Bossi, Anthony T.�C. Chan, (unknown), J.-P. Machiels	20
5	Reprint of “Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up” 2020 ·Oral Oncology ·J.-P. Machiels, C. René Leemans, Wojciech Golusiński, Cai Grau, Lisa Licitra, Vincent Grégoire	37
6	Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up breakdown → 2020 ·Annals of Oncology ·J.-P. Machiels, C. René Leemans, Wojciech Golusiński, Cai Grau, Lisa Licitra, Vincent Grégoire	477
7	Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR-T therapy in metastatic colorectal cancer 2019 ·Annals of Oncology ·Eric Van Cutsem, J.-P. Machiels, Marc Van den Eynde, Hans Prenen, Alain Hendlisz, (unknown), Javier Carrasco, Jean Luc Canon, Panagiota A. Sotiropoulou, Eytan Breman, (unknown), (unknown)	13
8	Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach 2018 ·Annals of Oncology ·Rachel Galot, Christophe Le Tourneau, J. Guigay, Lisa Licitra, Ingeborg Tinhofer, Anthony Kong, Carmela Caballero, Catherine Fortpied, Jan Bogaerts, Anne-Sophie Govaerts, (unknown), Tiana Raveloarivahy, (unknown), (unknown), Esma Saâda-Bouzid, J.-P. Machiels	48
9	Phase I studies assessing the safety and clinical activity of multiple doses of a NKG2D-based CAR-T therapy, CYAD-01, in metastatic colorectal cancer 2018 ·Annals of Oncology ·(unknown), Alain Hendlisz, (unknown), Sandrine Aspeslagh, Michaël Vouche, Vincent Donckier, Ahmad Awada, J.-P. Machiels, Marc Van den Eynde, J.-L. Canon, Javier Carrasco, Caroline Lonez, Frédéric Lehmann	1
10	Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial 2016 ·Annals of Oncology ·Paul M. Clément, Thomas Gauler, J.-P. Machiels, Robert I. Haddad, Jérôme Fayette, Lisa Licitra, Makoto Tahara, Ezra E.W. Cohen, Didier Cupissol, Juan J. Grau, J. Guigay, Francesco Caponigro, Gilberto de Castro, Luciano de Souza Viana, Ulrich Keilholz, J.M. del Campo, Xiuyu Julie Cong, E. Ehrnrooth, Jan B. Vermorken	31
11	A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck 2015 ·Cancer Chemotherapy and Pharmacology ·J.-P. Machiels, Pol Specenier, John C. Krauss, Andreas Dietz, (unknown), Yassine Lalami, Michael Henke, Ulrich Keilholz, Rainald Knecht, (unknown), Ivan D. Horak, (unknown), Stephan Braun, Thomas Gauler	21
12	New Targets in Squamous Cell Carcinoma 2014 ·Annals of Oncology ·J.-P. Machiels	1
13	Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck 2013 ·Annals of Oncology ·Sandra Schmitz, Marc Hamoir, H Reychler, Michèle Magremanne, Birgit Weynand, Renaud Lhommel, François‐Xavier Hanin, Thierry Duprez, Nicolas Michoux, Denis Rommel, Max Lonneux, (unknown), (unknown), J.-P. Machiels	23
14	Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02) 2012 ·Annals of Oncology ·Sandra Schmitz, (unknown), Stéphanie Henry, (unknown), L. Geoffrois, Emmanuelle Bompas, Anne Moxhon, Lionel Mignion, (unknown), L. Knoops, Marc Hamoir, J.-P. Machiels	62
15	A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: A phase I/II study 2011 ·European Journal of Cancer ·Cristian Villanueva, Ahmad Awada, Mario Campone, J.-P. Machiels, T. Besse, E. Magherini, Franck Dubin, Dorothée Sémiond, Xavier Pivot	51
16	A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer 2011 ·Breast Cancer Research and Treatment ·(unknown), Xavier Durando, Jean‐François Baurain, Yves Humblet, F Mazzeo, (unknown), (unknown), (unknown), J.-P. Machiels, (unknown)	7
17	Prognostic factors and assessment of staging systems for head and neck soft tissue sarcomas in adults 2010 ·European Journal of Surgical Oncology ·(unknown), Sandra Schmitz, J.-P. Machiels, Christine Galant, V. Grégoire, Benoît Lengelé, Marc Hamoir	40
18	Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma 2009 ·Annals of Oncology ·Chris Nutting, Carla M.L. van Herpen, Aisha Miah, Shree Bhide, J.-P. Machiels, Jan Buter, C. Kelly, Dominique de Raucourt, Kevin J. Harrington	134
19	BRONCHOBILIARY FISTULA AND CHOLANGIOCARCINOMA: A CASE REPORT AND PRINCIPLES OF MANAGEMENT 2007 ·Acta Clinica Belgica ·(unknown), Pierre Goffette, (unknown), Jacques Rahier, Carlos Graux, F Mazzeo, Yves Humblet, J.-P. Machiels	4
20	A Prospective Randomized Study of Two Alternating, Non Cross-Resistant Chemotherapies For Advanced Hodgkin’s Disease. 1992 ·Acta Clinica Belgica ·J.-P. Machiels, Augustin Ferrant, (unknown), Chantal Doyen, André Bosly, J. L. Michaux	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact